Work

Host-autonomous regeneration as a goal of cell and gene therapy for intervertebral disc degeneration

Year: 2026
Type: article
Abstract: Cell and gene therapies for intervertebral disc degeneration aim to restore tissue function, but cell survival, matrix accumulation and prolonged symptom improvement do not establish sustained regeneration. This Review examines recent evidence through host-autonomous regeneration: continued tissue renewal and functional maintenance by host-derived cells and their local microenvironment, with reduced dependence on a specified external therapeutic activity. We connect senescence-associated defects in genome maintenance, protein turnover and metabolism with impaired inflammatory clearance, progenitor depletion and regional mechanical constraints. These relationships explain why correcting one molecular response may leave synthesis, matrix retention or damage disposal inadequate. We compare endogenous gene regulation, donor-derived signalling and cell transplantation according to the functions they restore, and consider how materials, delivery and treatment timing support those functions. A deficit-directed approach is proposed in which additional components address demonstrated residual limitations rather than expand formulations without a defined purpose. Validation requires attribution of new matrix to its cellular source, measurement of effective treatment activity and assessment of tissue function under load. Human-relevant models and product-specific potency assays should connect these mechanisms with controlled patient outcomes. Host-autonomous regeneration remains a testable therapeutic objective. Persistent grafts, stable molecular correction and long-term material support may remain valuable, but their contributions must be resolved to explain what sustains repair and whether it benefits patients.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236691542
FWCI:
Cites: 158
Cited by:
Related to: 10